Showing results (171-180 of 204) with videos related to

Sort By:
Pageof 21
Plos One|September 24, 2013
Programmatically selected multidrug-resistant strains drive the emergence of extensively drug-resistant tuberculosis in South AfricaBorna Müller, Violet N Chihota, Manormoney Pillay, et al.
The International Journal of Tuberculosis and Lung Disease : the Official Journal of the International Union Against Tuberculosis and Lung Disease|January 13, 2012
Rise in rifampicin-monoresistant tuberculosis in Western Cape, South AfricaF K Mukinda, D Theron, G D van der Spuy, et al.
Antimicrobial Agents and Chemotherapy|August 30, 2021
Rifampicin-Monoresistant Tuberculosis Is Not the Same as Multidrug-Resistant Tuberculosis: a Descriptive Study from Khayelitsha, South AfricaZubeida Salaam-Dreyer, Elizabeth M Streicher, Frederick A Sirgel, et al.
Journal of Infection and Public Health|February 11, 2026
High treatment success among individuals with rifampicin-resistant tuberculosis in Botswana: A retrospective cohort studyTuelo Mogashoa, Justice T Ngom, Ontlametse T Choga, et al.
Plos One|May 6, 2016
Mapping of Mycobacterium tuberculosis Complex Genetic Diversity Profiles in Tanzania and Other African CountriesErasto V Mbugi, Bugwesa Z Katale, Elizabeth M Streicher, et al.
Cephalalgia : an International Journal of Headache|April 6, 2017
Kappa opioid receptor antagonists: A possible new class of therapeutics for migraine preventionJennifer Y Xie, Milena De Felice, Caroline M Kopruszinski, et al.
Ebiomedicine|February 26, 2025
Speeding up drug susceptibility testing in Mycobacterium tuberculosis using RNA biomarkersAmandine Sury, Margo Maex, Alain Baulard, et al.
Transboundary and Emerging Diseases|November 14, 2015
Isolation and Potential for Transmission of Mycobacterium bovis at Human-livestock-wildlife Interface of the Serengeti Ecosystem, Northern TanzaniaB Z Katale, E V Mbugi, K K Siame, et al.
Journal of Medicinal Chemistry|November 10, 2020
Synthesis and Pharmacology of a Novel μ-δ Opioid Receptor Heteromer-Selective Agonist Based on the Carfentanyl TemplateAbdelfattah Faouzi, Rajendra Uprety, Ivone Gomes, et al.
American Journal of Respiratory and Critical Care Medicine|March 13, 2025
Efficacy and Safety of Higher Doses of Levofloxacin for MDR-TB: A Randomized Placebo-controlled Phase 2 TrialPatrick Pj Phillips, Charles A Peloquin, Timothy R Sterling, et al.
Pageof 21